[HTML][HTML] Clearance of somatic mutations at remission and the risk of relapse in acute myeloid leukemia

K Morita, HM Kantarjian, F Wang, Y Yan… - Journal of Clinical …, 2018 - ncbi.nlm.nih.gov
K Morita, HM Kantarjian, F Wang, Y Yan, C Bueso-Ramos, K Sasaki, GC Issa, S Wang…
Journal of Clinical Oncology, 2018ncbi.nlm.nih.gov
Clearance of Somatic Mutations at Remission and the Risk of Relapse in Acute Myeloid
Leukemia - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI
Homepage MyNCBI Homepage Main Content Main Navigation Search PMC Full-Text
Archive Search in PMC Advanced Search User Guide Journal List J Clin Oncol
PMC6008108 Other Formats PDF (872K) Actions Cite Collections Share Permalink Copy
RESOURCES Similar articles Cited by other articles Links to NCBI Databases Journal List J …
Abstract
Purpose
The aim of the current study was to determine whether the degree of mutation clearance at remission predicts the risk of relapse in patients with acute myeloid leukemia (AML).
ncbi.nlm.nih.gov